Iovance Biotherapeutics paid its 7 named executives $9.4M in total in FY2025 (Dec). CEO Frederick G. Vogt, Ph.D., J.D. was paid $1.9M of that.
Pay$100 in the stock at the end of FY20 → $6
Pay of each named executive
Daniel KirbyChief Commercial Officer
| FY2025 (Dec) |
1 year
Frederick G. Vogt, Ph.D., J.D.Interim Chief Executive Officer and President, General Counsel
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) |
5 years
Corleen RocheChief Financial Officer
| FY2025 (Dec) |
1 year
Raj K. Puri, M.D., Ph.D.Chief Regulatory Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) |
2 years
Igor Bilinsky, Ph.D.Chief Operating Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) |
5 years
Matthew W. RosinackInterim Principal Financial Officer and Principal Accounting Officer
| FY2025 (Dec) |
1 year
Jean-Marc BelleminFormer Chief Financial Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) |
5 years
CEO pay against the pay peers
In FY2025 (Dec), the median CEO pay of the 10 peers with pay on file was $10.5M. CEO pay of Iovance Biotherapeutics for that year is not on file.
- 1BridgeBio Pharma
- 2Revolution Medicines
- 3Ionis Pharmaceuticals
- 4Cytokinetics
- 5Ultragenyx Pharmaceutical
- 6Arcus Biosciences
- 7CRISPR Therapeutics AG
- 8Beam Therapeutics
- 9Agios Pharmaceuticals
- 10Denali Therapeutics
- 11Iovance BiotherapeuticsThis companyNot disclosed
- 12Apellis Pharmaceuticals, Inc.Not disclosed
- 13Blueprint Medicines Corp.Not disclosed
- 14Crinetics Pharmaceuticals, Inc.Not disclosed
- 15Immunity Bio, Inc.Not disclosed
- 16Replimune Group, Inc.Not disclosed
- 17XencorNot disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.